CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Mateon Therapeutics Inc's Working Capital Ratio

OXGN's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




OXGN Working Capital Ratio (Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
Y / Y Current Liabilities Change 302.12 % 759.59 % 373.35 % 87.61 % 79.24 %
Y / Y Current Assets Change 313.77 % -76.14 % -86.79 % -82.42 % -83.36 %
Working Capital Ratio MRQ 0.1 0.03 0.04 0.03 0.09
Overall Ranking # 4479 # 4487 # 5157 # 5415 # 5360
Seq. Current Liabilities Change -3.16 % 25.08 % 152.13 % 31.67 % 107.02 %
Seq. Current Assets Change 185.61 % 0.42 % 284.34 % -62.46 % -83.53 %



Working Capital Ratio second quarter 2020 Comment
Mateon Therapeutics Inc's Current Assets grew by 185.61 % in II. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Mateon Therapeutics Inc's Working Capital Ratio to 0.1, Working Capital Ratio remained below Mateon Therapeutics Inc average.

Within Biotechnology & Drugs industry 215 other companies have achieved higher Working Capital Ratio than Mateon Therapeutics Inc in second quarter 2020. While Working Capital Ratio total ranking has improved so far to 4479, from total ranking in previous quarter at 4487.

Explain Working Capital Ratio
Where is OXGN most successful ?
Working Capital Ratio OXGN on the trailing twelve month basis
Working Capital Ratio second quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 216
Healthcare Sector # 833
Overall Market # 4478


Working Capital Ratio Statistics
High Average Low
45.33 11.28 0.03
(Mar 31 2015)  




Financial Statements
Mateon Therapeutics Inc's Current Liabilities $ 8 Millions Visit OXGN's Balance sheet
Mateon Therapeutics Inc's Current Assets $ 1 Millions Visit OXGN's Balance sheet
Source of OXGN's Sales Visit OXGN's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingJun 30 2020, within Biotechnology & Drugs Industry Working Capital RatioJun 30 2020 MRQ Current AssetsJun 30 2020 MRQ Current Liabilities
Azurrx Biopharma Inc   0.21 $ 1.637  Millions$ 7.616  Millions
Gtx Corp  0.19 $ 0.658  Millions$ 3.457  Millions
Cell Medx Corp   0.17 $ 0.157  Millions$ 0.943  Millions
Cardax Inc   0.14 $ 1.294  Millions$ 9.152  Millions
Twinlab Consolidated Holdings Inc   0.14 $ 17.103  Millions$ 124.048  Millions
Guided Therapeutics Inc  0.10 $ 0.855  Millions$ 8.630  Millions
Quest Patent Research Corp  0.10 $ 0.877  Millions$ 8.937  Millions
Mateon Therapeutics Inc  0.10 $ 0.783  Millions$ 8.217  Millions
Therapeutic Solutions International Inc   0.09 $ 0.190  Millions$ 2.033  Millions
Sangui Biotech International Inc  0.06 $ 0.049  Millions$ 0.792  Millions
Cannabis Global Inc   0.06 $ 0.169  Millions$ 2.822  Millions
Burzynski Research Institute Inc  0.04 $ 0.009  Millions$ 0.255  Millions
Gt Biopharma Inc   0.03 $ 0.971  Millions$ 28.562  Millions
Qrons Inc   0.02 $ 0.016  Millions$ 0.681  Millions
Skinvisible Inc   0.02 $ 0.056  Millions$ 2.365  Millions
Mymetics Corp  0.02 $ 1.514  Millions$ 68.769  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TMQ's Profile

Stock Price

TMQ's Financials

Business Description

Fundamentals

Charts & Quotes

TMQ's News

Suppliers

TMQ's Competitors

Customers & Markets

Economic Indicators

TMQ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071